1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Hemorrhagic Fever Global Clinical Trials Review, H2, 2014

Hemorrhagic Fever Global Clinical Trials Review, H2, 2014

  • November 2014
  • -
  • Global Data
  • -
  • 59 pages

Hemorrhagic Fever Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Hemorrhagic Fever Global Clinical Trials Review, H2, 2014" provides data on the Hemorrhagic Fever clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemorrhagic Fever. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hemorrhagic Fever. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Hemorrhagic Fever Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 5
Hemorrhagic Fever 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Hemorrhagic Fever to Infectious Disease Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Hemorrhagic Fever to Infectious Disease Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Hemorrhagic Fever 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Hemorrhagic Fever Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Sanofi 30
Clinical Trial Overview of Sanofi 30
Sarepta Therapeutics, Inc. 31
Clinical Trial Overview of Sarepta Therapeutics, Inc. 31
GlaxoSmithKline plc 32
Clinical Trial Overview of GlaxoSmithKline plc 32
Liaoning Cheng Da Biotechnology Co., Ltd 33
Clinical Trial Overview of Liaoning Cheng Da Biotechnology Co., Ltd 33
Clinical Trial Overview of Top Institutes / Government 34
U.S. Army Medical Research and Materiel Command 34
Clinical Trial Overview of U.S. Army Medical Research and Materiel Command 34
The National Institute of Allergy and Infectious Diseases 35
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 35
University of Maryland 36
Clinical Trial Overview of University of Maryland 36
Five Key Clinical Profiles 37
Appendix 57
Abbreviations 57
Definitions 57
Research Methodology 58
Secondary Research 58
About GlobalData 59
Contact Us 59
Disclaimer 59
Source 59

List of Tables

Hemorrhagic Fever Therapeutics, Global, Clinical Trials by Region, 2014* 6
Hemorrhagic Fever Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Hemorrhagic Fever Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Hemorrhagic Fever Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 9
Hemorrhagic Fever Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Hemorrhagic Fever Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Hemorrhagic Fever Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Hemorrhagic Fever Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Hemorrhagic Fever to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 14
Hemorrhagic Fever Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Hemorrhagic Fever Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Hemorrhagic Fever to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 17
Hemorrhagic Fever Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Hemorrhagic Fever Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Hemorrhagic Fever Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Hemorrhagic Fever Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Hemorrhagic Fever Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Hemorrhagic Fever Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Hemorrhagic Fever Therapeutics, Global, Withdrawn Clinical Trials, 2014* 24
Hemorrhagic Fever Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Hemorrhagic Fever Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Hemorrhagic Fever Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Hemorrhagic Fever Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Hemorrhagic Fever Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 30
Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarepta Therapeutics, Inc., 2014* 31
Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 32
Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by Liaoning Cheng Da Biotechnology Co., Ltd, 2014* 33
Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Army Medical Research and Materiel Command, 2014* 34
Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 35
Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Maryland, 2014* 36

List of Figures

Hemorrhagic Fever Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Hemorrhagic Fever Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Hemorrhagic Fever Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Hemorrhagic Fever Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 9
Hemorrhagic Fever Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 13
Proportion of Hemorrhagic Fever to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 14
Hemorrhagic Fever Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Hemorrhagic Fever Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Hemorrhagic Fever to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 17
Hemorrhagic Fever Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Hemorrhagic Fever Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Hemorrhagic Fever Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Hemorrhagic Fever Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Hemorrhagic Fever Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Hemorrhagic Fever Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Hemorrhagic Fever Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Hemorrhagic Fever Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Hemorrhagic Fever Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Hemorrhagic Fever Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 58

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the ...

Pharmacovigilance Market: By Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial); By Type of Service Providers (In House, Contract Outsourcing) & By Region-Forecast (2016-2022)

Pharmacovigilance Market: By Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial); By Type of Service Providers (In House, Contract Outsourcing) & By Region-Forecast (2016-2022)

  • $ 5274
  • Industry report
  • September 2016
  • by Industry ARC

Pharmacovigilance is referred to as a practice of monitoring the effects of medical drugs after they have been licensed for use, especially in order to identify and evaluate previously unreported adverse ...

Global Clinical Trials Market

December 2016 $ 4250

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.